发明名称 Aminoquinazoline derivatives and their salts and methods of use thereof
摘要 Provided herein are aminoquinazoline compounds, salts and uses thereof. The compounds have Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof. Also provided herein are pharmaceutical compositions containing the compounds disclosed herein, and uses of the compounds or the compositions for preventing, managing, treating or lessening the severity of a proliferative disorder in a patient and for modulating the protein tyrosine kinase activity.;
申请公布号 US9556191(B2) 申请公布日期 2017.01.31
申请号 US201414774702 申请日期 2014.04.28
申请人 SUNSHINE LAKE PHARMA CO., LTD. 发明人 Zhang Yingjun;Liu Bing;Liu Jinlei;Zhang Jiancun;Cheng Changchung
分类号 A01N43/54;A61K31/517;C07D239/72;C07D491/056;A61K31/5415;A61K31/553;C07D413/12;C07D417/12;C07D403/12;C07D401/12;C07D495/04;C07D497/04;C07D498/04;C07D519/00;A61K31/196;A61K31/198;A61K31/255;A61K31/475;A61K31/675;A61K31/282;A61K31/337;A61K31/4545;A61K31/5377;A61K31/538;A61K31/5383;A61K31/573;A61K31/7008;A61K31/704;A61K33/24;A61K38/12;A61K38/21;A61K39/395;C07D491/044;C07D491/048;A61K39/00 主分类号 A01N43/54
代理机构 Squire Patton Boggs (US) LLP 代理人 Law Kam W.;Squire Patton Boggs (US) LLP
主权项 1. A compound having Formula (I): or a stereoisomer, a geometric isomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof, wherein R is wherein each X and X1a is independently O, S, S(═O), S(═O)2 or NRa; X1b is O, S, S(═O), or S(═O)2; X1c is S, S(═O) or S(═O)2; each Y, Y1, and Y2 is independently O, S, S(═O), S(═O)2, NRa or CRbRb′; Y1a is O, S, S(═O), S(═O)2, or CRbRb′; each Y3 is independently CRb″ or N; wherein each Ra is independently H, D or C1-3 alkyl; each Rb, Rb′ and Rb″ is independently H, D, F, Cl, Br, I, —OH, —NO2, —NH2, —CN, C1-3 alkyl, C1-3 alkoxy or C1-3 alkylamino; each R7 is independently H, D, F, Cl, Br, I, —OH, —SH, —NO2, —NH2, —CN, —COOH, C1-6 alkyl, C1-6 heteroalkyl, C1-6 alkylamino, C1-6 alkoxy, C2-6 alkenyl, C2-6 alkynyl, C3-8 cycloalkyl, C2-10 heterocyclyl, C6-10 aryl, C6-10 aryl-C1-6-alkyl, C6-10 aryloxy, C6-10 aryl-C1-6-alkoxy or C1-9 heteroaryl; each d is independently 0, 1, 2, 3, 4 or 5; e is 0, 1, 2, or 3; f is 0 or 1; L is a bond, O or S; R1 is H, D, F, Cl, Br, I, —OH, —NO2, —NH2, —CN, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy-C1-6-alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkylamino-C1-6-alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl-C16-alkyl, C3-8 cycloalkyl-C2-6-alkenyl, C3-8 cycloalkyl-C2-6-alkynyl, C3-8 cycloalkyloxy-C2-6-alkynyl, C2-10 heterocyclyl, C2-10 heterocyclyl-C1-6-alkyl, C2-10 heterocyclyl-C2-6-alkenyl, C2-10 heterocyclyl-C2-6-alkynyl, C5-12 fused bicyclyl, C5-12 fused bicyclyl-C1-6-alkyl, C5-12 fused bicyclyl-C2-6-alkenyl, C5-12 fused bicyclyl-C2-6-alkynyl, C5-12 fused heterobicyclyl, C5-12 fused heterobicyclyl-C1-6-alkyl, C5-12 fused heterobicyclyl-C2-6-alkenyl, C5-12 fused heterobicyclyl-C2-6-alkynyl, C5-12 spiro bicyclyl, C5-12 spiro bicyclyl-C1-6-alkyl, C5-12 spiro bicyclyl-C2-6-alkenyl, C5-12 spiro bicyclyl-C2-6-alkynyl, C5-12 spiro heterobicyclyl, C5-12 spiro heterobicyclyl-C1-6-alkyl, C5-12 spiro heterobicyclyl-C2-6-alkenyl, C5-12 spiro heterobicyclyl-C2-6-alkynyl, C6-10 aryl, C6-10 aryl-C1-6-alkyl, C1-9 heteroaryl or C1-9 heteroaryl-C1-6-alkyl; R2 is H, F, Cl, Br, I, —NH2, —NO2, —CN or C1-6 alkyl; each of R3 and R4 is independently H, D or C1-4 alkyl; R5 is H; Ar is wherein each R6 is independently H, D, F, Cl, Br, I, C2-6 alkynyl, C6-10 aryl-C1-6-alkoxy, or C1-9 heteroaryl-C1-6-alkoxy; k is 0, 1, 2, 3, 4 or 5; and Ry is H or C6-10 aryl-C1-6-alkyl, wherein optionally each of alkyl, alkoxy, alkoxyalkyl, alkylamino, alkylaminoalkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, cycloalkyloxyalkynyl, heterocyclyl, heterocyclylalkyl, heterocyclylalkenyl, heterocyclylalkynyl, fused bicyclyl, fused bicyclylalkyl, fused bicyclylalkenyl, fused bicyclylalkynyl, fused heterobicyclyl, fused heterobicyclylalkyl, fused heterobicyclylalkenyl, fused heterobicyclylalkynyl, spiro bicyclyl, spiro bicyclylalkyl, spiro bicyclylalkenyl, spiro bicyclylalkynyl, spiro heterobicyclyl, spiro heterobicyclylalkyl, spiro heterobicyclylalkenyl, spiro heterobicyclylalkynyl, aryl, aryloxy, arylalkyl, arylalkoxy, arylamino, heteroaryl, heteroarylalkyl, heteroarylalkoxy, heteroaryloxy, alkylthio, alkylcarbonyl, alkylacylamino, alkylsulfonyl, haloalkyl and alkylsulfinyl is independently substituted with one or more substituents independently selected from D, F, Cl, Br, I, —OH, —NO2, —NH2, —CN, —COOH, C1-3 alkyl, C1-3 alkoxy, C1-3 alkylamino, C1-3 alkylthio, C6-10 aryl, C6-10 aryloxy, C6-10 arylamino, C1-9 heteroaryl, C1-9 heteroaryloxy, C3-8 cycloalkyl, C3-8 cycloalkyloxy, C2-10 heterocyclyl and C5-12 fused heterobicyclyl, and wherein optionally each of C1-3 alkyl, C1-3 alkoxy, C1-3 alkylamino, C1-3 alkylthio, C6-10 aryl, C6-10 aryloxy, C6-10 arylamino, C1-9 heteroaryl, C1-9 heteroaryloxy, C3-8 cycloalkyl, C3-8 cycloalkyloxy, C2-10 heterocyclyl and C5-12 fused heterobicyclyl is independently substituted with one or more substituents independently selected from D, F, Cl, Br, I, —OH, —NO2, —NH2, —CN, —COOH, C1-3 alkyl, deuterated C1-3 alkyl, C1-3 haloalkyl and hydroxy-substituted C1-3 alkyl.
地址 Dongguan, Guangdong CN